Efficacy and safety of short‐term dual antiplatelet therapy (≤6 months) after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta‐analysis of randomized controlled trials

Naoki Misumida(University of Kentucky), Khaled M. Ziada(Cleveland Clinic), Gbolahan Ogunbayo(University of Kentucky), Ahmed Abdel‐Latif(University of Kentucky), Mohamed Abo‐Aly(University of Kentucky), Sun Moon Kim(University of Kentucky)
Clinical Cardiology
September 18, 2018
10.1002/clc.23075
Cited by 27

Related Papers

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
|The Lancet|2018|781
Extent and Direction of Arterial Remodeling in Stable Versus Unstable Coronary Syndromes
|Circulation|2000|751
High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults
|Circulation|2001|681
Temporal Trends and Outcomes of Mechanical Complications in Patients With Acute Myocardial Infarction
|JACC: Cardiovascular Interventions|2019|374
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study
|The Lancet|2009|298